14 research outputs found
Fobia de deglutição: remissão com terapia comportamental
OBJECTIVE: A phobic behavior pattern is learned by classical and operant conditioning mechanisms. The present article reviews the main determinants of choking phobia etiology and describes the behavior therapy of an adult patient. METHOD: Psychoeducation, functional analysis, and graded exposure to aversive stimuli were used to treat the patient, after extensive psychiatric and psychological assessment. Ingesta and anxiety levels were measured along treatment and at follow-up. RESULTS: A multiple assessment baseline design was used to demonstrate the complete remission of symptoms after seven sessions, each of them exposing the patient to a different group of foods. CONCLUSION: Psychoeducation and exposure were critical components of a successful choking phobia treatment.OBJETIVO: O padrão comportamental da fobia é adquirido com base no condicionamento clássico e mecanismos operantes de aprendizagem. Este artigo faz uma revisão dos principais determinantes da etiologia da fobia de deglutição e descreve o tratamento da terapia comportamental em uma paciente adulta. MÉTODO: Foram usadas psicoeducação, análise funcional e gradativa exposição a estÃmulos aversivos no tratamento da paciente, depois de uma extensiva avaliação psiquiátrica e psicológica. NÃveis de ingesta e ansiedade foram medidos ao longo de todo o tratamento e no follow-up. RESULTADOS: Para demonstrar a completa remissão dos sintomas, após sete sessões de exposição a diferentes grupos de alimentos foi usado um delineamento de linha de base de avaliações múltiplas. CONCLUSÃO: Terapia de exposição e psicoeducação foram componentes que contribuÃram de modo crÃtico para a obtenção de resultados positivos ao tratamento
Aplicação da estimulação magnética transcraniana de repetição no tratamento do transtorno obsessivo-compulsivo e outros transtornos de ansiedade
A estimulação magnética transcraniana de repetição (EMTr) vem sendo amplamente investigada como ferramenta terapêutica em transtornos psiquiátricos, especialmente a depressão. Neste trabalho, compilamos as informações provenientes de estudos que investigaram as aplicações da EMTr no tratamento dos transtornos de ansiedade: transtorno do pânico (TP), transtorno de estresse pós-taumático (TEPT), transtorno de ansiedade generalizada (TAG) e especialmente o transtorno obsessivo compulsivo (TOC). Três estudos foram publicados abordando o tratamento do TOC, sendo que utilizaram metodologias e parâmetros de aplicação extremamente diversos, dificultando a obtenção de informações conclusivas sobre a efetividade deste tratamento. Quatro estudos publicados sobre TEPT e EMTr também apresentam dados conflitantes e pouco comparáveis, mas destaca-se publicação recente com desenho duplo-cego e resultados positivos. Quanto ao TP e o TAG, apenas pequenas investigações iniciais foram realizadas. Conclusão: Apesar dos estudos citados, não há dados conclusivos sobre a eficácia terapêutica da EMTr nos transtornos de ansiedade. Isto se dá especialmente devido aos estudos com amostras pequenas e desenho aberto. Portanto, devem ser realizados estudos mais aprofundados para que possamos obter estas respostas.Repetitive transcranial magnetic stimulation (rTMS) have been widely studied as a therapeutic method in psychiatric disorders, specially in major depression. In this paper, we have compiled the information from studies concerning the use of rTMS as a therapeutic tool for anxiety disorders: panic disorder (PD), post-traumattic stress disorder (PTSD), generalized anxiety disorder (GAD) and mainly obsessive-compulsive disorder (OCD).Three studies have been published concerning treatment of OCD with rTMS, but they are very different in their methods and in the application parameters and location, making it difficult to draw any conclusion about the efficacy of rTMS in this cases. Four studies published on PTSD also showed very ambiguous and hardly comparable data, but a recent double-blind study with positive results is discussed. Very few inicial investigations are available concerning PD and GAD. Conclusion: Although many studies are mentioned, thete is no conclusive data about the therapeutic efficacy of rTMS in anxiety disorders. It is mainly due to a large number of open-labelled studies with small sample sizes. Therefore, studies with a deeper approach are needed to provide this answers
The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
Objective: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in the central nervous system (CNS) which might be explained by suppression of defensive fixed action patterns. Previous studies have proposed that higher baseline 5-HT concentration and slow decrease in concentration during drug treatment of OCD were predictors of good clinical response to 5-HT reuptake inhibitors. The objective of this study was to investigate whether pre-treatment platelet rich plasma (PRP) 5-HT concentration is associated with latency of treatment response and final response to an ERP protocol for obsessive-compulsive disorder (OCD). Methods: Thirty adult and treatment-free OCD patients were included in an 8-week, 16-session ERP protocol. 5-HT concentration was determined at baseline and after treatment. Patients with a reduction ≥30% on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at the end of ERP were defined as responders. Results: A positive correlation between baseline 5-HT concentration and reduction of symptoms on the Y-BOCS was observed after 4 weeks. Baseline 5-HT concentration was not correlated with clinical response after 8 weeks of ERP, possibly due to the similar though delayed clinical response of patients with lower (compared to those with higher) baseline 5-HT concentration. Patients with higher 5-HT baseline concentration also showed more improvement in depressive symptoms with treatment. Conclusion: The present results partially support the hypothesis of a stress endurance effect of 5-HT in OCD patients. According to the literature, fast onset responders possibly have more or larger 5-HT containing neurons, higher endogenous 5-HT synthesis or lower monoamine oxidase activity; all these hypotheses remain to be investigated
Choking phobia: full remission following behavior therapy Fobia de deglutição: remissão com terapia comportamental
OBJECTIVE: A phobic behavior pattern is learned by classical and operant conditioning mechanisms. The present article reviews the main determinants of choking phobia etiology and describes the behavior therapy of an adult patient. METHOD: Psychoeducation, functional analysis, and graded exposure to aversive stimuli were used to treat the patient, after extensive psychiatric and psychological assessment. Ingesta and anxiety levels were measured along treatment and at follow-up. RESULTS: A multiple assessment baseline design was used to demonstrate the complete remission of symptoms after seven sessions, each of them exposing the patient to a different group of foods. CONCLUSION: Psychoeducation and exposure were critical components of a successful choking phobia treatment.<br>OBJETIVO: O padrão comportamental da fobia é adquirido com base no condicionamento clássico e mecanismos operantes de aprendizagem. Este artigo faz uma revisão dos principais determinantes da etiologia da fobia de deglutição e descreve o tratamento da terapia comportamental em uma paciente adulta. MÉTODO: Foram usadas psicoeducação, análise funcional e gradativa exposição a estÃmulos aversivos no tratamento da paciente, depois de uma extensiva avaliação psiquiátrica e psicológica. NÃveis de ingesta e ansiedade foram medidos ao longo de todo o tratamento e no follow-up. RESULTADOS: Para demonstrar a completa remissão dos sintomas, após sete sessões de exposição a diferentes grupos de alimentos foi usado um delineamento de linha de base de avaliações múltiplas. CONCLUSÃO: Terapia de exposição e psicoeducação foram componentes que contribuÃram de modo crÃtico para a obtenção de resultados positivos ao tratamento
Serotonin and Sensitivity to Trauma-Related Exposure in Selective Serotonin Reuptake Inhibitors-Recovered Posttraumatic Stress Disorder
Background: Selective serotonin reuptake inhibitors (SSRIs) are first-line treatments for posttraumatic stress disorder (PTSD). Serotonergic (5HT) attenuation of stress sensitivity is postulated from SSRIs` effects in other anxiety disorders, and we studied this in PTSD. Methods: Ten patients with PTSD fully recovered on SSRIs (Clinical Global Impression Scale-I 1 and 2) were enrolled in the study. Patients were tested on two occasions I week apart; in each session, they received a drink containing large neutral amino acids (LNAAs) either with (sham tryptophan depletion [STD], control) or without (acute tryptophan depletion [ATD]) tryptophan. At 5.5 hours after the drink, subjects were exposed to a trauma-related exposure challenge. Self-reports of PTSD (visual analogue scales [VAS] and the Davidson Trauma Scale [DTSI), anxiety (Spielberger State Inventory [STAI] Form Y-1), and mood (Profile of Mood States [POMS]) were obtained. Heart rate (HR), systolic (SBP) and diastolic (DBP) blood pressure were also measured. Results: The trauma-related exposure challenge induced anxiety on both days, with more marked responses on the ATD day according to VAS, DTS, POMS, and DBP (p < .05). A trend of significance (.1 > p >.05) was observed for STAI Form Y-1, HR, and SBP. Conclusions: These data demonstrate that ATD accentuates responses to trauma-related stimuli in SSRI-recovered PTSD. They also suggest that SSRI-induced increases in serotonin function restrain PTSD symptoms, especially under provocation, supporting a role for serotonin in mediating stress resilience.FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[2008/04122-5]FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[99/00170-4
Abuse liability of intra-nasal midazolam in inhaled-cocaine abusers
Intra-nasally instilled benzodiazepines have been proposed for acute anxiety episodes. However, routes with faster absorption may increase abuse liability. This study compared abuse liability of intra-nasal midazolam between subjects with a history of intra-nasal drug abuse and non-psychiatric subjects on a single-blind randomized controlled trial. Thirty-one inhaled-cocaine abusers and 34 normal volunteers received either 1 mg intra-nasal midazolam or active placebo. Visual analogue scales assessing desire to repeat the experience (ER) and Experience Liking (EL) assessed abuse liability. Profile analysis for repeated measures showed a significant effect of time over ER (F-[5,F-57]=3.311, p=0.011) and EL (F-[5,F-57]=3.947, p=0.004), diagnostic group (cocaine abusers scoring higher on both - F-[5,F-57]=5.229, p=0.026; F-[5,F-57]=4.946, p=0.030), regardless of the administered substance. It is concluded that the intra-nasal route does not seem to pose risks for non-psychiatric individuals, but it may represent a risk in itself for subjects with a history of drug abuse through this path. (C) 2008 Elsevier B.V. and ECNP. All rights reserved.State of Sao Paulo Research Funding Agency (FAPESP), Brazil[97/12461-8]Post-Graduation Enhancement Coordination Foundation (CAPES), Brazi
Depression in chronic migraine: severity and clinical features Depressão em migrânea crônica: aspectos clÃnicos e gravidade
INTRODUCTION: Chronic migraine (CM) is a common medical condition affecting 2.4% of the general population. Depression is one of the most frequent comorbid disorders in CM. METHOD: Seventy patients diagnosed with chronic migraine were studied. All patients evaluated filled out the Beck Depression Inventory (BDI). Depression severity was divided into none or minimal depression, mild, moderate, and severe. RESULTS: BDI ranged from 4 to 55, mean 21 ± 10.7. Moderate or severe depression, were present in 58.7% of the patients . Some degree of depression appeared in 85.8% of patients. The BDI scores correlated with pain intensity (p = 0.02). Severe depression was more frequent in patients with comorbid fibromyalgia and in patients reporting fatigue. CONCLUSION: The BDI is an easy tool to access depression in CM patients. Suicide risk assessment is needed in CM patients. Patients with fibromyalgia and fatigue are at even higher risk for severe depression.INTRODUÇÃO: A migrânea crônica (MC) é uma doença comum, que afeta 2,4% da população geral. A depressão é uma das comorbidades mais frequentes em enxaqueca. MÉTODO: Setenta pacientes diagnosticados com migrânea crônica foram estudados. Todos os pacientes preencheram o Inventário de Depressão Beck.(BDI). A gravidade da depressão foi dividida em nenhuma ou leve, mÃnima, moderada, e grave. RESULTADOS: O BDI variou de 4 a 55, média 21 ± 10,7. A depressão moderada ou grave esteve presente em 58,7% dos pacientes. Algum grau de depressão foi observado em 85,8% dos pacientes. Os escores de depressão correlacionaram-se com a intensidade da dor. A depressão grave foi mais freqüente em paciente com comorbidade com fibromialgia e fadiga. CONCLUSÃO: O BDI é um instrumento de fácil avaliação da depressão em MC. A identificação do risco de suicÃdio é necessária nestes pacientes. Fibromialgia e fadiga são fatores de risco para depressão grave